NewDays raises $16M seed round led by Madrona and General Catalyst, expands AI-driven dementia care to Nevada
Seattle startup NewDays closed a $16 million seed round led by Madrona and General Catalyst to scale a telehealth program combining clinicians with an AI companion, Sunny, for treating mild dementia; early research suggests the platform may preserve about 18 months of cognitive function and the service now operates in six states including Nevada.
Seattle Startup NewDays Raises $4.5M to Expand AI Therapy Platform for Mild Dementia Patients
Seattle startup NewDays raised an additional $4.5 million for its generative AI therapy platform that offers telehealth visits and AI-driven cognitive therapies for people with mild dementia. The total funding now stands at $11.5 million to expand its services and advance its AI companion Sunny.
From Google and Amazon to NewDays: Why These Tech Vets Bet on AI for Dementia
In this episode of Founded & Funded, Madrona Managing Director Tim Porter sits down with Babak Parviz and Daniel Kelly, co-founders of NewDays, a platform purpose-built for older Americans living with cognitive change to help them reclaim abilities, preserve independence, and keep being themselves. Babak and Daniel share how their experience at Amazon and Google led them to apply AI in the most human way: helping people with dementia and mild cognitive impairment (MCI) with scalable solutions. They dive into: Why we chose to build at the intersection of AI and cognitive health How to translate clinical science into accessible…
Organizations
-
NewDays Director 2025–present · current